MTOR and Alzheimer disease: The interruption of PI3K/AKT in AD may inhibit the mammalian target of rapamycin (mTOR), which is indirectly involved in amyloid accumulation (O' Neill, 2013; Cao et al., 2021; Querfurth and Lee, 2021).